Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: FDA reform

This article was originally published in The Tan Sheet

Executive Summary

FDA reform: Health claims provision in Sen. James Jeffords' (R-Vt.) FDA reform bill (S 830) is "troublesome," FDA Lead Deputy Commissioner Michael Friedman, MD, states in written comments prepared for a June 18 meeting of food industry execs. Friedman criticizes the provision, saying "it would allow certain scientific determinations without considering the totality of evidence as FDA now does under current law." Introduced by Sen. Judd Gregg (R.-N.H.), the provision would allow the marketing of food health claims not approved by FDA provided the claims are publicly supported by a scientific department of the U.S. government, such as the National Institutes of Health or the Centers for Disease Control & Prevention ("The Tan Sheet" June 23, p. 14). The provision "could allow an inaccurate, misleading health claim to go to market, and FDA would have to disprove claims after the fact to get it off the label," Friedman concludes...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087266

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel